Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: -0.025 (-1.59%)
Spread: 0.10 (6.667%)
Open: 1.575
High: 1.575
Low: 1.55
Prev. Close: 1.575
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

Thu, 07th Dec 2023 15:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Comptoir Group PLC - Owner and operator of a chain of Lebanese restaurants - Opens new restaurant at the Southbank Centre, London. The restaurant will be located opposite the entrance of the Royal Festival Hall, neighbouring Las Iguanas, Cote Brasserie and Honest Burgers restaurants. Says that with over 5,400 events a year, the Southbank Centre site has a footfall of 19 million a year. Expects to open restaurant around Easter next year. Chief Executive Nick Ayerst says: "Following the successful recent opening in Ealing, we are pleased to announce the continued strategic growth in an area of London we have long desired to be in. The location on the South Bank captures an immensely high footfall of both workers, visitors and tourists who we know will be hungry for our well-loved authentic Middle Eastern food and culture."

----------

Intercede Group PLC - Lutterworth, England-based cybersecurity software - Wins a professional services order to help deploy MyID Credential Management Solution to "large US Federal Agency." Says it is the same customer which it won a contract with on Tuesday. Says additional order, worth USD800,000, underpins the company's upgraded financial 2024 and 2025 forecasts. "Once again, I am pleased to announce a further order that supports our upgraded forecasts for FY24 and FY25. This is a testament of the hard work my colleagues have done and indeed continue to do so," says CEO Klaas van der Leest. On Tuesday, Intercede said it signed a "major" new contract with the unnamed large US federal agency, with purchase orders received of perpetual licences worth around USD6.6 million. Due to the order, the company expects its financial year 2024 results to be "significantly ahead of market expectations," which it says are a revenue of GBP13.7 million and adjusted earnings before interest, tax, depreciation and amortisation of GBP1.8 million.

----------

Datalex PLC - Dublin-based software company, which specialises in digital retail technology for the airline market - Announces the go live of its Datalex Merchandiser product with easyJet PLC, a Luton Airport-based low-cost airline. Says easyJet is set to begin its migration to Datalex Direct and Datalex Dynamic in 2024 to drive next generation retailing and an improved booking experience. Chief Revenue Officer Bryan Porter says: "We are proud to be partnering with easyJet to drive forward the airline's digital retail strategy, supporting high value revenue growth and enhancing the exceptional customer experience for easyJet's customers. The recent go live is a major milestone in our journey, and we look forward to continuing to provide the airline with superior and innovative digital retailing capabilities that will enable them to deliver new, revenue generating and differentiated customer experiences."

----------

Wynnstay Properties PLC - Powys, Wales-based agricultural and specialist merchanting firm - Exchanges contracts for the acquisition from three members of the Gunne family of Units 1-4, 18a Wildmere Road, Banbury, and Unit 14, The IO Centre, Whittle Way, Stevenage, for GBP2.5 million in total. The Banbury property is freehold and comprises two industrial buildings, separately let to established national and regional trade counter businesses, with service yards and an access road. The total rent passing is GBP103,425 per year. The Stevenage Property is held on a 999-year lease at a nominal rent and comprises a mid-terrace industrial unit. The rent passing on the single occupational sub-lease to an established national trade counter business is GBP57,550 per annum. The acquisition in expected to complete at the beginning of 2024. Chris Betts, Managing Director of Wynnstay, says: "The acquisition of these highly accessible and well-let properties broadens the geographic spread of Wynnstay's portfolio and enhances our focus on the growth potential of the light industrial/trade counter warehouse sector."

----------

Develop North PLC - investor in residential and commercial property sector advised by Newcastle, England-based Tier One Capital Ltd - Extends share buyback programme. Says it will repurchase up to a further GBP500,000. The programme will end December 31. The purchased shares will be held in treasury.

----------

Eqtec PLC - Thermochemical conversion technology company - Signs an equipment supply agreement for engineering services and equipment supply for a plant in Wilseyville, California, US. The plant is being developed to cleanly convert approximately 25,000 tonnes per year of wood waste into synthesis gas to fuel a gas engine coupled to alternators for production of about 3.0 MWe electricity. The Agreement is with Blue Mountain Electric Company LLC, a project company set up and operated by Phoenix Biomass Energy Inc. Expects to commence basic engineering work in early 2024 and to invoice about USD330,000 for this work, which the company expects to complete in the first half of 2024.

----------

Videndum PLC - London-based manufacturer of hardware and software for the content creation market, including broadcasters and film studios - Raises GBP125 million through placing and open offer. Raises GBP75 million through placing of 28.1 million shares and GBP50 million through open offer of 18.7 million shares. CEO Stephen Bird says: "We are pleased with the very strong response to the capital raising and I would like to thank both our shareholders and new investors for their support. We now have a robust capital base which will enable Videndum to focus its resources on strategic execution and long-term value creation for shareholders through our market-leading, premium brands which are focused on the content creation market."

----------

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Updates shareholders on third quarter US commercial highlights. Total prescriptions reach over 27,750, up 76% from the second quarter. Notes US third quarter net revenue of USD4.1 million. CEO Greg Madison comments: "Shield continues to make excellent progress on the US commercial launch of Accrufer. As we approach the one-year anniversary of the announcement of the Viatris agreement, I am pleased to report that the collaboration continues to deliver excellent results, based on the stand-out performance of the combined commercial team, which has produced consistent and strong sequential prescription growth and key performance indicators, which are trending towards previous guidance."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Aug 2023 17:07

CORRECT: Biogens, Sage Therapeutics postpartum depression drug okayed

(Correcting the name of Sage Therapeutics Inc. Please ignore incorrect coding of Shield Therapeutics PLC.)

Read more
6 Aug 2023 14:17

Biogens, Sage Therapeutics postpartum depression treatment approved

(Alliance News) - The US Food & Drug Administration has approved Zurzuvae, zuranolone, 50 mg for adults with postpartum depression, Sage Therapeutics PLC and Biogen Inc said in a statement.

Read more
20 Jul 2023 11:43

IN BRIEF: Shield Therapeutics prescription orders up in first quarter

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Sees strong prescription growth in the second quarter and first half of 2023. Total prescriptions for second quarter increase 50% to 15,800 compared to the first quarter. In first half of 2023, total prescriptions grow to around 26,300 which exceeds total prescription volumes for all of 2022. The company says that this growth in the first half means Shield is likely to meet its 2023 goal for US Accrufer prescriptions.

Read more
21 Jun 2023 15:43

UK shareholder meetings calendar - next 7 days

Thursday 22 June 
Alphawave IP Group PLCAGM
Angling Direct PLCAGM
Anglo Asian Mining PLCAGM
boohoo Group PLCAGM
Braime Group PLCAGM
Card Factory PLCAGM
Ergomed PLCAGM
Falcon Oil & Gas LtdAGM
Futura Medical PLCAGM
Good Energy Group PLCAGM
Grand Vision Media Holdings PLCAGM
Longboat Energy PLCAGM
MaxRets Ventures PLCAGM
Pathfinder Minerals PLCAGM
RBG Holdings PLCAGM
Robinson PLCAGM
Sanderson Design Group PLCAGM
Team17 Group PLCAGM
Trellus Health PLCAGM
Whitbread PLCAGM
Friday 23 June 
Cadogan Petroleum PLCAGM
Mears Group PLCAGM
Non-Standard Finance PLCAGM
Ocean Harvest Technology Group PLCAGM
Oxford Biomedica PLCAGM
Pelatro PLCAGM
Petrofac LtdAGM
Princess Private Equity Holding LtdAGM
Rathbones Group PLCGM re agreement regarding all-share combination with Invested Wealth & Investment Ltd
Supply@Me Capital PLCGM re open offer warrant holders
Vietnam Enterprise Investments LtdAGM
VPC Specialty Lending Investments PLCAGM
Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
27 Apr 2023 18:13

IN BRIEF: Shield Therapeutics pretax loss doubles despite revenue rise

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Reports revenue in the year to December 31 trebled to GBP4.5 million from GBP1.5 million a year before. Says net product revenue from sales of Accrufer in the US totalled GBP2.9 million, up from GBP0.1 million while royalty revenue from product sales in Europe reached GBP1.4 million, up from GBP0.9 million.

Read more
5 Apr 2023 12:38

IN BRIEF: Shield appoints Andy Hurley as chief commercial officer

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Appoints Andy Hurley as chief commercial officer, effective from April 10.

Read more
9 Feb 2023 11:19

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
9 Feb 2023 10:50

Shield Therapeutics 2022 revenue jumps on Accrufer iron tablet sales

(Alliance News) - Shield Therapeutics PLC on Thursday said revenue in 2022 rose amid a jump in sales of its Accrufer iron tablets, also known as Feraccru.

Read more
9 Jan 2023 20:41

TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Jan 2023 17:11

Shield Therapeutics completes GBP2.6 million open offer

(Alliance News) - Shield Therapeutics PLC on Thursday said it has raised GBP2.6 million through an open offer.

Read more
29 Dec 2022 13:40

UK shareholder meetings calendar - next 7 days

Friday 30 December 
Amala Foods PLCAGM
Apollon Formularies PLCAGM
Europa Metals LtdGM re Denarius transaction
Goldplat PLCAGM
Ncondezi Energy LtdAGM
Ross GroupAGM
Secure Property Development & Investment PLCAGM
Time Out Group PLCAGM
Monday 02 January 
no events scheduled 
Tuesday 03 January 
no events scheduled 
Wednesday 04 January 
Thor Mining PLCGM re name change to Thor Energy PLC
Borders & Southern Petroleum PLCGM re fundraising
Thursday 05 January 
AfriTin Mining LtdEGM re name change
Shield Therapeutics PLCGM re share transaction
  
Copyright 2022 Alliance News Ltd. All Rights Reserved.

Read more
13 Dec 2022 16:50

TRADING UPDATES: Longboat Energy extends loan for drilling programme

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
13 Dec 2022 12:06

Shield Therapeutics plans share offer; agrees Accrufer collaboration

(Alliance News) - Shield Therapeutics PLC on Tuesday said it plans a share offer to raise fresh funds, while it also has agreed a sales collaboration with Viatris Inc in the US for the oral therapy Accrufer.

Read more
31 Oct 2022 21:00

TRADING UPDATES: Goldplat sells shares; Chill Brands starts campaigns

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
27 Oct 2022 14:44

TRADING UPDATES: Gusbourne toasts vintage; Hardide supplies Leonardo

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.